222 related articles for article (PubMed ID: 23163963)
1. NMR solution structure and condition-dependent oligomerization of the antimicrobial peptide human defensin 5.
Wommack AJ; Robson SA; Wanniarachchi YA; Wan A; Turner CJ; Wagner G; Nolan EM
Biochemistry; 2012 Dec; 51(48):9624-37. PubMed ID: 23163963
[TBL] [Abstract][Full Text] [Related]
2. Human defensin 5 disulfide array mutants: disulfide bond deletion attenuates antibacterial activity against Staphylococcus aureus.
Wanniarachchi YA; Kaczmarek P; Wan A; Nolan EM
Biochemistry; 2011 Sep; 50(37):8005-17. PubMed ID: 21861459
[TBL] [Abstract][Full Text] [Related]
3. Different dynamics and pathway of disulfide bonds reduction of two human defensins, a molecular dynamics simulation study.
Zhang L
Proteins; 2017 Apr; 85(4):665-681. PubMed ID: 28106297
[TBL] [Abstract][Full Text] [Related]
4. Dynamics of human defensin 5 (HD5) self-assembly in solution: Molecular simulations/insights.
Chairatana P; Niramitranon J; Pongprayoon P
Comput Biol Chem; 2019 Dec; 83():107091. PubMed ID: 31349122
[TBL] [Abstract][Full Text] [Related]
5. Conformational landscape and pathway of disulfide bond reduction of human alpha defensin.
Snijder J; van de Waterbeemd M; Glover MS; Shi L; Clemmer DE; Heck AJ
Protein Sci; 2015 Aug; 24(8):1264-71. PubMed ID: 25970658
[TBL] [Abstract][Full Text] [Related]
6. The conserved salt bridge in human alpha-defensin 5 is required for its precursor processing and proteolytic stability.
Rajabi M; de Leeuw E; Pazgier M; Li J; Lubkowski J; Lu W
J Biol Chem; 2008 Aug; 283(31):21509-18. PubMed ID: 18499668
[TBL] [Abstract][Full Text] [Related]
7. Functional determinants of human enteric α-defensin HD5: crucial role for hydrophobicity at dimer interface.
Rajabi M; Ericksen B; Wu X; de Leeuw E; Zhao L; Pazgier M; Lu W
J Biol Chem; 2012 Jun; 287(26):21615-27. PubMed ID: 22573326
[TBL] [Abstract][Full Text] [Related]
8. Solution NMR studies of the A beta(1-40) and A beta(1-42) peptides establish that the Met35 oxidation state affects the mechanism of amyloid formation.
Hou L; Shao H; Zhang Y; Li H; Menon NK; Neuhaus EB; Brewer JM; Byeon IJ; Ray DG; Vitek MP; Iwashita T; Makula RA; Przybyla AB; Zagorski MG
J Am Chem Soc; 2004 Feb; 126(7):1992-2005. PubMed ID: 14971932
[TBL] [Abstract][Full Text] [Related]
9. Discovery and characterization of a disulfide-locked C(2)-symmetric defensin peptide.
Wommack AJ; Ziarek JJ; Tomaras J; Chileveru HR; Zhang Y; Wagner G; Nolan EM
J Am Chem Soc; 2014 Oct; 136(39):13494-7. PubMed ID: 25181039
[TBL] [Abstract][Full Text] [Related]
10. NMR structure and conformational dynamics of AtPDFL2.1, a defensin-like peptide from Arabidopsis thaliana.
Omidvar R; Xia Y; Porcelli F; Bohlmann H; Veglia G
Biochim Biophys Acta; 2016 Dec; 1864(12):1739-1747. PubMed ID: 27592418
[TBL] [Abstract][Full Text] [Related]
11. Reconstruction of the conserved beta-bulge in mammalian defensins using D-amino acids.
Xie C; Prahl A; Ericksen B; Wu Z; Zeng P; Li X; Lu WY; Lubkowski J; Lu W
J Biol Chem; 2005 Sep; 280(38):32921-9. PubMed ID: 15894545
[TBL] [Abstract][Full Text] [Related]
12. Solution structure of cryptdin-4, a mouse paneth cell alpha-defensin.
Jing W; Hunter HN; Tanabe H; Ouellette AJ; Vogel HJ
Biochemistry; 2004 Dec; 43(50):15759-66. PubMed ID: 15595831
[TBL] [Abstract][Full Text] [Related]
13. Reduction of human defensin 5 affords a high-affinity zinc-chelating peptide.
Zhang Y; Cougnon FB; Wanniarachchi YA; Hayden JA; Nolan EM
ACS Chem Biol; 2013 Sep; 8(9):1907-11. PubMed ID: 23841778
[TBL] [Abstract][Full Text] [Related]
14. Structure and antimicrobial activity of platypus 'intermediate' defensin-like peptide.
Torres AM; Bansal P; Koh JM; Pagès G; Wu MJ; Kuchel PW
FEBS Lett; 2014 May; 588(9):1821-6. PubMed ID: 24694388
[TBL] [Abstract][Full Text] [Related]
15. Conformational analysis of the eight-membered ring of the oxidized cysteinyl-cysteine unit implicated in nicotinic acetylcholine receptor ligand recognition.
Creighton CJ; Reynolds CH; Lee DH; Leo GC; Reitz AB
J Am Chem Soc; 2001 Dec; 123(50):12664-9. PubMed ID: 11741432
[TBL] [Abstract][Full Text] [Related]
16. Solution structure and activity of the synthetic four-disulfide bond Mediterranean mussel defensin (MGD-1).
Yang YS; Mitta G; Chavanieu A; Calas B; Sanchez JF; Roch P; Aumelas A
Biochemistry; 2000 Nov; 39(47):14436-47. PubMed ID: 11087396
[TBL] [Abstract][Full Text] [Related]
17. Key Determinants of Human α-Defensin 5 and 6 for Enhancement of HIV Infectivity.
Valere K; Lu W; Chang TL
Viruses; 2017 Aug; 9(9):. PubMed ID: 28850095
[TBL] [Abstract][Full Text] [Related]
18. The adsorption of human defensin 5 on bacterial membranes: simulation studies.
Awang T; Pongprayoon P
J Mol Model; 2018 Sep; 24(10):273. PubMed ID: 30187138
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial activity and structure of a consensus human β-defensin and its comparison to a novel putative hBD10.
Rodriguez A; Pedersen MØ; Villegas E; Rivas-Santiago B; Villegas-Moreno J; Amero C; Norton RS; Corzo G
Proteins; 2020 Jan; 88(1):175-186. PubMed ID: 31325337
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationships in defensin dimers: a novel link between beta-defensin tertiary structure and antimicrobial activity.
Campopiano DJ; Clarke DJ; Polfer NC; Barran PE; Langley RJ; Govan JR; Maxwell A; Dorin JR
J Biol Chem; 2004 Nov; 279(47):48671-9. PubMed ID: 15317821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
